Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 148-reexam: Non-Final Action Mailed on 12-21-2007
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Any connection between the timing of the USPTO's action and the judge's signing of the orders dismissing the case? Seems more than just coincidence to me! These patents are likely to emerge from PTO consideration stronger than before.

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply